Kent Nastiuk, PhD

Assistant Professor of Oncology
Member, Cell and Molecular Biology (Graduate Program)
Member, Genitourinary Cancers CCSG Program
Department of Cancer Genetics and Genomics
Department of Urology
Roswell Park Cancer Institute

Make an appointment online or call us at 1-800-Roswell Request an Appointment

Special Interests: 
(#1) Androgen deprivation therapy (ADT)-induced apoptosis
(#2) ADT resistance mechanisms
(#3) Sarcopenia (muscle loss) in response to ADT
(#4) Targeted therapy for prostate diseases (cancer and BPH)
(#5) Imaging of prostate cancer


Dr. Nastiuk is a translational cancer researcher who joined the Roswell Park Cancer Institute faculty in 2015.  He studied neurobiology (B.S. with high honors) at Oberlin College and molecular neuroendocrinology (Ph.D.) at The Rockefeller University.  He completed fellowship training in protein biochemistry (Rockefeller) and prostate cancer genetics (Columbia P&S) before developing his research program examining the mechanism of endocrine therapy in prostate cancer at UC Irvine.  Prior to coming to Roswell, he initiated investigations into the mechanism of therapy induced progression and developing enhanced specificity in imaging of localized prostate cancers at the University of Rochester.


Education and Training: 
1996-1998: Post-Doctoral Research Scientist
Dept. of Pathology & Laboratory Medicine, Columbia University, College of Physicians & Surgeons
New York, NY
1992-1996: Post-Doctoral Fellow
Laboratory of Molecular and Cellular Neuroscience, Rockefeller University
New York, NY
1992- PhD Molecular Neuroendocrinology - The Rockefeller University, New York, NY